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Introduction
The systemic migration of sclerosant is a rare complication 
of endoscopic injection sclerotherapy. Serious complications, 
such as embolization to the brain,
1) lungs,
2) and portal veins
3) 
have been occasionally reported. However, it is not well known 
how systemic sclerosant migration occurs. 
We report a rare case of sclerosant migration presenting as 
an intracardiac mass after endoscopic sclerotherapy for vari-
ceal bleeding, and demonstrate the entire migration route.  
Case 
A 34-year-old man with hepatits B virus-related liver cirrho-
sis (Child-Pugh Score B), was referred to our clinic for an in-
tracardiac mass detected incidentally by transthoracic echo-
cardiography. Six months previously, he had been treated with 
an endoscopic injection of a mixture of n-butyl-2-cyanoacry-
late (Histoacryl) and Lipiodol for control of variceal bleeding. 
At presentation, the patient had no cardiac symptoms. On phy-
sical examination, his vital signs were stable and he had nor-
mal respiratory and cardiovascular findings. His sclerae were 
icteric and his abdomen was distended with ascites. A chest X-
ray was unremarkable. 
Two-dimensional echocardiography revealed an intracardi-
ac mass in the right atrium (RA) that appeared to extend from 
the inferior vena cava. It was a 5 cm elongated, hypermobile st-
ructure (Fig. 1). The echogenic mass, suggestive of a thrombus, 
resembled a blood vessel.
Even though it appeared to extend from the inferior vena 
cava, the exact origin was not clearly demonstrated by echo-
cardiography. Portal-phase abdominal computed tomography 
(CT) with coronal reconstruction identified the origin of the 
elongated intracardiac mass (Fig. 2). After originating from 
varices at the gastroesophageal junction, a partially radio-opa-
que and radiolucent intraluminal material, consistent with a 
mixture of sclerosant and thrombus, traversed a gastrorenal 
shunt, extended through the inferior vena cava, and stopped in 
the RA.
Close clinical observation was undertaken for 2 weeks. Fol-
low-up echocardiography showed no significant interval 
change compared with the initial study, and no cardiac symp-
toms developed. The patient did not manifest any signs or sy-
mptoms of systemic embolization by sclerosant. He was dis-
charged without any significant problems, and remains as-
ymptomatic on regular follow-up.
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ABSTRACT
A 34-year-old man, who had been treated with an endoscopic injection of a mixture of n-butyl-2-cyanoacrylate (Histoacryl) 
and Lipiodol for control of variceal bleeding 6 months previously, presented with an intracardiac mass in the right atrium (RA). 
Two-dimensional echocardiography revealed an intracardiac mass in the RA that appeared to extend from the inferior vena 
cava. The origin of the sclerosant was traced by computed tomography (CT). This is a very rare case in which the sclerosant mi-
gration route was demonstrated by CT scan. The findings of this case suggest that the systemic migration of sclerosant into an 
intracardiac chamber should be considered in patients with an intracardiac mass, especially with a history of previous sclero-
therapy for variceal bleeding. (Korean Circ J 2010;40:468-470)
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Discussion
Endoscopic injection of a mixture of Histoacryl and Lipi-
odol has been reported to be an optimal and effective therapy 
for variceal bleeding.
4) Reported complications of this treat-
ment include fever, ulceration at the injection site, chest pain, 
and dysphagia.
3) A few case reports have documented systemic 
embolization of sclerosant as one of the uncommon compli-
cations after sclerotherapy.
1-3) In this report, intracardiac scle-
rosant located in the RA was demonstrated by echocardiog-
raphy.
Histoacryl is a watery solution that polymerizes and hard-
   
   
   
   
Fig. 2. Portal-phase abdominal computed tomography scans with coronal reconstruction demonstrate a partial radio-opaque and radiolucent 
intraluminal material consistent with a mixture of sclerosant and thrombus, which originates from the gastroesophageal junction (1) and 
forms an intraluminal and intracardiac mass traversing a gastrorenal shunt (2), the left renal vein (3), the inferior vena cava (4) and right 
atrium (5).
Fig. 1. Transthoracic echocardiography shows an elongated intracardiac mass in the right atrium (arrow), which appears to extend from the infe-
rior vena cava. A: parasternal short axis view, aortic valve level. B: off-axis modified four-chamber view.
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ens instantaneously on contact with blood.
5) To prevent nee-
dle immobilization in a varix, Lipiodol serves as a diluent that 
delays Histoacryl polymerization.
6) Delayed polymerization 
may increase the possibility of systemic migration,
7) and rapid 
injection may increase intravariceal pressure and induce mi-
gration of the sclerosant before complete polymerization.
8) In 
addition, a large injected volume of the Histoacryl and Lipi-
odol mixture may contribute to systemic migration. In patien-
ts with varices associated with a gastrosystemic venous shunt, 
endoscopic sclerotherapy presents a potential risk for migra-
tion of the sclerosant into the systemic venous circulation.
9) 
However, it is not well known how sclerosant migration oc-
curs, mainly because patients are not routinely imaged after 
sclerotherapy. In addition, sclerosant migration and emboli-
zation are difficult to diagnose using CT, because the sclero-
sant is masked by contrast.
10) 
In 2006, Lee et al.
11) reported a rare case of acrylic cement 
foreign body in the RA and central veins after vertebroplas-
ty, and suggested that an acrylic cement foreign body should 
be considered as a potential source of pulmonary embolism. 
There has been no report of an echocardiographic demon-
stration of intracardiac sclerosant in the RA following endo-
scopic sclerotherapy for varices, in addition to illustration of 
the entire sclerosant migration route. In the present case, por-
tal-phase CT clearly visualized the entire sclerosant migration 
route along with thrombus on the sclerosant plug, thereby 
documenting that systemic migration of sclerosant occurs via 
a gastrosystemic venous shunt. This case indicates that system-
ic migration of sclerosant into an intracardiac chamber sh-
ould be considered in patients with an intracardiac mass, espe-
cially with a history of previous sclerotherapy for variceal 
bleeding.
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